1/ My notes on #Fintech. My biggest concern with Fintech is so many of these companies are now highly linked to crypto. I have my own crypto portfolio and the biggest fear here is crypto turns out to be a fad and goes away.
2/ This means companies like $COIN who is 100% about crypto are highly levered to this risk. That is not my base case, but it is a risk I must diversify away from. I went through $COIN, $SQ and $HOOD.
3/ I will make $SQ my top pick in this space. It does have some risk with its big #Bitcoin segment, but its all about the electronic payments and cash app for me. I love those business and there seems to be little competition in the small business payments space.
4/ I really liked $COIN, but I fear its all about crypto. Owing it would give me high leverage toward crypto. It seems like the wise choice to find something that isn't all about crypto in the #Fintech space.
5/ I went over $HOOD this morning. It is more about stock trading app then it is about crypto; even though, they are expanding into crypto. It has been crushed as it was the trading app of choice from pandemic traders.
6/ I know my Nephew was one of them. Every day it was about Crypto this or space stocks or EV stocks. Now I haven't heard from him in 2 months lol. I guess that checks off the bubble bursting.
7/ I think $HOOD has to shrink after the bubble popped and can grow from that lower more healthy level. That would allow them to build at a more sustainable pace. The big question will be if they are up to that task.
3/ Due to my desire to be diverse beyond crypto, I have $PYPL, $SOFI and $AFRM to still do today. I plan to have my top 2 or 3 picks in this space today. I hope.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
2/ Allogeneic CAR-T takes T cells from healthy donors to create the CAR-T therapies. This is done by extracting the T cells from the donor. Then they insert the CAR receptor. They often use gene editing technologies like CRISPR to make additional edits.
2/ The first generation of CAR therapies started with Autologous. This was a long process that started with the drawing of blood and leukapheresis to extract the T cells. These T cells go through editing to insert the CAR receptor into each T cell.
I went through $SQ, $COIN, $HOOD, $PYPL, $AFRM and $SOFI. I looked at what each company offers as services. I listened to the Q1 calls to see if the management seems to be competent.
Then I went through the valuation, future potential and risks. I crossed off $PYPL on lack of future growth potential. They are already at $30 billion sales only growing about 13% a year.
I funded it today and it will be just like I am starting out from scratch. I got $350 in it and plan to contribute about $200 to $250 each month. I went through much of my portfolio design which I will share so it might be educational.
1/ This portfolio will not be a buy and hold portfolio. It will shift and rotate based on where I think the Macro economy sits and where the best deals are in the market. That is the first thing I want to establish.
2/ I set a few rules so I buy 1 share at a time since there are zero fees. I plan to not pay up for stocks, but not sure if that will work once the bear market ends so its a guide not rule at the moment.
I set up 2 trades today. I setup that Strategy account a few weeks ago with just $50 in it. I didn't want to contribute till the end of May. Then I used it to trade $MGTA and made a few bucks off of it. Now I am setting up a bid for $VERV. I know its only a few shares.
I figured a few shares is better than nothing and I could always buy more at the end of the month when I contribute to that Strategy account. I was very skeptical of the company because of the competition in Cholesterol space.
Now, I am betting on it down here on the management team. I have been impressed with them, and I am always willing to bet on good management. It doesn't hurt that its so cheap.